These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29112482)

  • 21. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 22. From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.
    MacGregor C; Petersen A; Munsie M
    Health (London); 2021 Jan; 25(1):51-68. PubMed ID: 31081381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pfizer Australia faces scrutiny over atorvastatin advertising campaign.
    Sweet M
    BMJ; 2012 May; 344():e3463. PubMed ID: 22589531
    [No Abstract]   [Full Text] [Related]  

  • 24. Direct-to-consumer marketing: the Food and Drug Administration is not alone.
    Kalb PE; Dunlop KO; McEnroe DC; Stein SD
    Food Drug Law J; 2003; 58(1):25-33. PubMed ID: 12739582
    [No Abstract]   [Full Text] [Related]  

  • 25. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 26. Marketing and Advertising Rules.
    CDA Practice Support
    J Calif Dent Assoc; 2015 Aug; 43(8):467-8, 470. PubMed ID: 26357818
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of direct-to-consumer advertising.
    Navarro RP
    Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419
    [No Abstract]   [Full Text] [Related]  

  • 28. Social media marketing still subject to advertising rules.
    Nicol G
    Todays FDA; 2012; 24(4):24-5, 27. PubMed ID: 22856272
    [No Abstract]   [Full Text] [Related]  

  • 29. The tobacco industry's code of advertising in the United States: myth and reality.
    Richards JW; Tye JB; Fischer PM
    Tob Control; 1996; 5(4):295-311. PubMed ID: 9130364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circumventing the WHO Code? An observational study.
    Berry NJ; Jones SC; Iverson D
    Arch Dis Child; 2012 Apr; 97(4):320-5. PubMed ID: 21719442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marketing of healthcare services in Denmark: the concept of misleading advertising.
    Aagaard L
    Int J Clin Pharm; 2020 Dec; 42(6):1524-1527. PubMed ID: 32789762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ban on television advertising of online medical services is lifted.
    Moberly T
    BMJ; 2014 Jun; 348():g4039. PubMed ID: 24939882
    [No Abstract]   [Full Text] [Related]  

  • 33. [Announcement of an advertised medical practice in the branch telephone book. Decision of the Federal Administrative Court on November 13, 1997].
    Rieger HJ
    Dtsch Med Wochenschr; 1998 Jul; 123(30):918-21. PubMed ID: 9711176
    [No Abstract]   [Full Text] [Related]  

  • 34. Is marketing through Groupon legal?
    Schulte D
    J Mich Dent Assoc; 2011 Dec; 93(12):16. PubMed ID: 22479859
    [No Abstract]   [Full Text] [Related]  

  • 35. The new drug marketing: a consumer protection perspective.
    Woodward D
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract]   [Full Text] [Related]  

  • 36. Healthcare advertising: what you can and cannot say.
    Barney DR
    Healthspan; 1985 Jan; 2(1):3-10. PubMed ID: 10271480
    [No Abstract]   [Full Text] [Related]  

  • 37. Marketing nutrition & health-related benefits of food & beverage products: enforcement, litigation & liability issues.
    Roller S; Pippins R
    Food Drug Law J; 2010; 65(3):447-69, i. PubMed ID: 24479235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of health services advertising.
    Barney DR
    Hosp Health Serv Adm; 1983; 28(3):85-110. PubMed ID: 10299216
    [No Abstract]   [Full Text] [Related]  

  • 39. New challenges for medical product promotion and its regulation.
    Pines WL
    Food Drug Law J; 1997; 52(1):61-5. PubMed ID: 10346710
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
    Turner L
    Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.